<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Serum <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) level is genetically determined and remains almost constant throughout life </plain></SENT>
<SENT sid="1" pm="."><plain>Based on this property, we investigated the serum <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) levels of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> patients in the <z:hpo ids='HP_0011010'>chronic</z:hpo> stage (mean period after <z:hpo ids='HP_0001297'>stroke</z:hpo>, 27 months) and its relation to the types of <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We measured serum <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) levels in 101 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and 37 <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects, taking the clinical profiles into consideration </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:chebi fb="1" ids="6495">Lipoprotein</z:chebi>(a) levels in patients with atherothrombotic <z:hpo ids='HP_0001297'>stroke</z:hpo> were 28.0 +/- 19.6 mg/dL (mean +/- SD), which were significantly (P &lt; .01) higher than those in patients with lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo> and in <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects (16.4 +/- 13.5 and 11.7 +/- 10.5 mg/dL, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) levels in patients with atherothrombotic <z:hpo ids='HP_0001297'>stroke</z:hpo> were significantly higher in the subgroup who were a younger age at <z:hpo ids='HP_0003674'>onset</z:hpo>: <z:hpo ids='HP_0003674'>onset</z:hpo> before age 50 years, 35.3 +/- 20.5; <z:hpo ids='HP_0003674'>onset</z:hpo> at age 50 to 59, 35.4 +/- 21.7; <z:hpo ids='HP_0003674'>onset</z:hpo> at age 60 to 69, 17.0 +/- 12.8; and <z:hpo ids='HP_0003674'>onset</z:hpo> at age 70 or older, 16.3 +/- 6.8 mg/dL (P &lt; .01 for <z:hpo ids='HP_0003674'>onset</z:hpo> before age 50 versus 60 to 69 years or 70 years or older; P &lt; .01 for <z:hpo ids='HP_0003674'>onset</z:hpo> at 50 to 59 years versus 60 to 69 years or 70 years or older) </plain></SENT>
<SENT sid="5" pm="."><plain>Serum <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) was significantly increased (40.2 +/- 20.1 mg/dL) in young adults with atherothrombotic <z:hpo ids='HP_0001297'>stroke</z:hpo> (<z:hpo ids='HP_0003674'>onset</z:hpo> at younger than age 45 years) compared with that in patients older than 45 years (P &lt; .01) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: We conclude that <z:chebi fb="1" ids="6495">lipoprotein</z:chebi>(a) is a genetic, independent, and critical risk factor for <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, especially in young adults </plain></SENT>
</text></document>